Anda di halaman 1dari 24

Adams, Pharmacology for Nurse: A Pathophysiologic Approach, 4/E Chapter 20

Question 1 Type: MCMA Several senior citizens have asked the nurse to do a presentation on degenerative diseases. What does the nurse plan to teach as the most common degenerative diseases? Note: Credit will be given onl i! all correct choices and no incorrect choices are selected. Standard Text: Select all that appl . 1. Am otrophic lateral sclerosis 2. Multiple sclerosis 3. Alzheimer"s disease 4. #untington"s chorea . $arkinson"s disease Corre!t Ans"er: %&' #ationa$e 1: Alzheimer"s disease and $arkinson"s disease are the two most common diseases o! the central nervous s stem. Multiple sclerosis is not as common as Alzheimer"s disease and $arkinson"s disease. #untington"s chorea is not as common as Alzheimer"s disease and $arkinson"s disease. Am otrophic lateral sclerosis is not as common as Alzheimer"s disease and $arkinson"s disease. #ationa$e 2: Alzheimer"s disease and $arkinson"s disease are the two most common diseases o! the central nervous s stem. Multiple sclerosis is not as common as Alzheimer"s disease and $arkinson"s disease. #untington"s chorea is not as common as Alzheimer"s disease and $arkinson"s disease. Am otrophic lateral sclerosis is not as common as Alzheimer"s disease and $arkinson"s disease. #ationa$e 3: Alzheimer"s disease and $arkinson"s disease are the two most common diseases o! the central nervous s stem. Multiple sclerosis is not as common as Alzheimer"s disease and $arkinson"s disease. #untington"s chorea is not as common as Alzheimer"s disease and $arkinson"s disease. Am otrophic lateral sclerosis is not as common as Alzheimer"s disease and $arkinson"s disease. #ationa$e 4: Alzheimer"s disease and $arkinson"s disease are the two most common diseases o! the central nervous s stem. Multiple sclerosis is not as common as Alzheimer"s disease and $arkinson"s disease. #untington"s chorea is not as common as Alzheimer"s disease and $arkinson"s disease. Am otrophic lateral sclerosis is not as common as Alzheimer"s disease and $arkinson"s disease. #ationa$e : Alzheimer"s disease and $arkinson"s disease are the two most common diseases o! the central nervous s stem. Multiple sclerosis is not as common as Alzheimer"s disease and $arkinson"s disease. #untington"s
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

chorea is not as common as Alzheimer"s disease and $arkinson"s disease. Am otrophic lateral sclerosis is not as common as Alzheimer"s disease and $arkinson"s disease. %$o&a$ #ationa$e: Co'niti(e )e(e$: Appl ing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: $lanning )earnin' ,ut!ome: +,/Question 2 Type: MCSA 0he patient is diagnosed with $arkinson"s disease. 0he patient"s wi!e asks the nurse how taking medicine will help her husband. What is the best response b the nurse? 1. 10he medications will help prevent muscle wasting in our husband.1 2. 10he medications will boost our husband"s appetite and energ .1 3. 10he medications will balance serotonin and acet lcholine in our husband"s brain.1 4. 10he medications will help our husband to eat and walk.1 Corre!t Ans"er: ( #ationa$e 1: 0he goal o! pharmacotherap !or $arkinson"s disease is to increase the abilit o! the patient to per!orm activities o! dail living 2A34s5 such as walking& eating& dressing& and bathing. Medications do not prevent muscle wasting. Medications do not boost appetite or energ . 0he medications help restore balance between dopamine& not serotonin& and acet lcholine. #ationa$e 2: 0he goal o! pharmacotherap !or $arkinson"s disease is to increase the abilit o! the patient to per!orm activities o! dail living 2A34s5 such as walking& eating& dressing& and bathing. Medications do not prevent muscle wasting. Medications do not boost appetite or energ . 0he medications help restore balance between dopamine& not serotonin& and acet lcholine. #ationa$e 3: 0he goal o! pharmacotherap !or $arkinson"s disease is to increase the abilit o! the patient to per!orm activities o! dail living 2A34s5 such as walking& eating& dressing& and bathing. Medications do not prevent muscle wasting. Medications do not boost appetite or energ . 0he medications help restore balance between dopamine& not serotonin& and acet lcholine. #ationa$e 4: 0he goal o! pharmacotherap !or $arkinson"s disease is to increase the abilit o! the patient to per!orm activities o! dail living 2A34s5 such as walking& eating& dressing& and bathing. Medications do not prevent muscle wasting. Medications do not boost appetite or energ . 0he medications help restore balance between dopamine& not serotonin& and acet lcholine. %$o&a$ #ationa$e:
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

Co'niti(e )e(e$: Appl ing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: .mplementation )earnin' ,ut!ome: +,/% Question 3 Type: MCMA 0he nurse plans to teach a class about Alzheimer"s disease to a caregiver"s support group. What will the best plan b the nurse include? Note: Credit will be given onl i! all correct choices and no incorrect choices are selected. Standard Text: Select all that appl . 1. 3epression and aggressive behavior are common with the disease. 2. Alzheimer"s disease accounts !or about ',6 o! all dementias. 3. 7lutamergic inhibitors are the most common class o! drugs !or treating Alzheimer"s disease. 4. Chronic in!lammation o! the brain ma be a cause o! the disease. . Memor di!!iculties are an earl s mptom o! the disease. Corre!t Ans"er: -&(&' #ationa$e 1: Memor di!!iculties are an earl s mptom o! Alzheimer"s disease. .t is suspected that chronic in!lammation and e8cess !ree radicals ma cause neuron damage& and contributes to the disease. 3epression and aggressive behavior are common s mptoms o! the disease. Alzheimer"s disease accounts !or about 9,6 o! all dementias. 0he acet lcholinesterase inhibitors& not the glutamergic inhibitors& are the most widel used class o! drugs !or treating the disease. #ationa$e 2: Memor di!!iculties are an earl s mptom o! Alzheimer"s disease. .t is suspected that chronic in!lammation and e8cess !ree radicals ma cause neuron damage& and contributes to the disease. 3epression and aggressive behavior are common s mptoms o! the disease. Alzheimer"s disease accounts !or about 9,6 o! all dementias. 0he acet lcholinesterase inhibitors& not the glutamergic inhibitors& are the most widel used class o! drugs !or treating the disease. #ationa$e 3: Memor di!!iculties are an earl s mptom o! Alzheimer"s disease. .t is suspected that chronic in!lammation and e8cess !ree radicals ma cause neuron damage& and contributes to the disease. 3epression and aggressive behavior are common s mptoms o! the disease. Alzheimer"s disease accounts !or about 9,6 o! all dementias. 0he acet lcholinesterase inhibitors& not the glutamergic inhibitors& are the most widel used class o! drugs !or treating the disease.
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

#ationa$e 4: Memor di!!iculties are an earl s mptom o! Alzheimer"s disease. .t is suspected that chronic in!lammation and e8cess !ree radicals ma cause neuron damage& and contributes to the disease. 3epression and aggressive behavior are common s mptoms o! the disease. Alzheimer"s disease accounts !or about 9,6 o! all dementias. 0he acet lcholinesterase inhibitors& not the glutamergic inhibitors& are the most widel used class o! drugs !or treating the disease. #ationa$e : Memor di!!iculties are an earl s mptom o! Alzheimer"s disease. .t is suspected that chronic in!lammation and e8cess !ree radicals ma cause neuron damage& and contributes to the disease. 3epression and aggressive behavior are common s mptoms o! the disease. Alzheimer"s disease accounts !or about 9,6 o! all dementias. 0he acet lcholinesterase inhibitors& not the glutamergic inhibitors& are the most widel used class o! drugs !or treating the disease. %$o&a$ #ationa$e: Co'niti(e )e(e$: Appl ing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: $lanning )earnin' ,ut!ome: +,/: Question 4 Type: MCSA 0he nurse plans care !or a patient with $arkinson"s disease. What will the best plan b the nurse include? 1. Monitor the patient !or the abilit to chew and swallow. 2. Check peripheral circulation !or thrombophlebitis. 3. Monitor the patient !or ps chotic s mptoms. 4. 4imit e8ercise to decrease the possibilit o! !ractures. Corre!t Ans"er: #ationa$e 1: .n $arkinson"s disease& muscle !unction is lost& and the patient"s abilit to chew and swallow to prevent aspiration becomes a sa!et issue. $s chosis is possible; however this is not the primar concern. Activit is important to maintain as much muscle tone as possible& and should not be limited. 0hrombophlebitis is not related to $arkinson"s disease. #ationa$e 2: .n $arkinson"s disease& muscle !unction is lost& and the patient"s abilit to chew and swallow to prevent aspiration becomes a sa!et issue. $s chosis is possible; however this is not the primar concern. Activit is important to maintain as much muscle tone as possible& and should not be limited. 0hrombophlebitis is not related to $arkinson"s disease. #ationa$e 3: .n $arkinson"s disease& muscle !unction is lost& and the patient"s abilit to chew and swallow to prevent aspiration becomes a sa!et issue. $s chosis is possible; however this is not the primar concern. Activit
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

is important to maintain as much muscle tone as possible& and should not be limited. 0hrombophlebitis is not related to $arkinson"s disease. #ationa$e 4: .n $arkinson"s disease& muscle !unction is lost& and the patient"s abilit to chew and swallow to prevent aspiration becomes a sa!et issue. $s chosis is possible; however this is not the primar concern. Activit is important to maintain as much muscle tone as possible& and should not be limited. 0hrombophlebitis is not related to $arkinson"s disease. %$o&a$ #ationa$e: Co'niti(e )e(e$: Anal zing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: $lanning )earnin' ,ut!ome: +,/+ Question Type: MCSA 0he patient receives levodopa 24arodopa5. 0he nurse has completed medication education and determines that learning has occurred when the patient makes which statement? 1. 1. need to increase m dail intake o! protein.1 2. 1. must increase the !iber in m diet.1 3. 1. need to check m pulse be!ore taking the medication.1 4. 1. must avoid ellow vegetables in m diet.1 Corre!t Ans"er: + #ationa$e 1: <iber will help prevent constipation& which is a side e!!ect o! levodopa 24arodopa5. 0here isn"t an need to check the pulse prior to the medication. 0here isn"t an need to avoid ellow vegetables. 0here isn"t an need to increase the dail intake o! protein. #ationa$e 2: <iber will help prevent constipation& which is a side e!!ect o! levodopa 24arodopa5. 0here isn"t an need to check the pulse prior to the medication. 0here isn"t an need to avoid ellow vegetables. 0here isn"t an need to increase the dail intake o! protein. #ationa$e 3: <iber will help prevent constipation& which is a side e!!ect o! levodopa 24arodopa5. 0here isn"t an need to check the pulse prior to the medication. 0here isn"t an need to avoid ellow vegetables. 0here isn"t an need to increase the dail intake o! protein. #ationa$e 4: <iber will help prevent constipation& which is a side e!!ect o! levodopa 24arodopa5. 0here isn"t an need to check the pulse prior to the medication. 0here isn"t an need to avoid ellow vegetables. 0here isn"t an need to increase the dail intake o! protein.
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

%$o&a$ #ationa$e: Co'niti(e )e(e$: Appl ing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: *valuation )earnin' ,ut!ome: +,/' Question Type: MCSA 0he nurse prepares to administer benztropine 2Cogentin5 to the patient. 0he nurse holds the dose and noti!ies the ph sician based on which assessment !inding? 1. A respirator rate o! -( 2. A pulse o! -,+ 3. =lood pressure o! >>):, mm#g 4. A temperature o! -,,.+?< Corre!t Ans"er: + #ationa$e 1: =enztropine 2Cogentin5 can cause tach cardia. .nitial h potension ma occur& but this is uncommon. An elevated temperature is not related to benztropine 2Cogentin5. A respirator rate o! -( is a normal !inding. #ationa$e 2: =enztropine 2Cogentin5 can cause tach cardia. .nitial h potension ma occur& but this is uncommon. An elevated temperature is not related to benztropine 2Cogentin5. A respirator rate o! -( is a normal !inding. #ationa$e 3: =enztropine 2Cogentin5 can cause tach cardia. .nitial h potension ma occur& but this is uncommon. An elevated temperature is not related to benztropine 2Cogentin5. A respirator rate o! -( is a normal !inding. #ationa$e 4: =enztropine 2Cogentin5 can cause tach cardia. .nitial h potension ma occur& but this is uncommon. An elevated temperature is not related to benztropine 2Cogentin5. A respirator rate o! -( is a normal !inding. %$o&a$ #ationa$e: Co'niti(e )e(e$: Anal zing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: Assessment )earnin' ,ut!ome: +,/@ Question . Type: MCSA
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

0he patient receives aspirin& a multivitamin& and an antihistamine ever da . What is the best instruction b the nurse prior to administering levodopa 24arodopa5? 1. 1Aou should not take the aspirin with our levodopa 24arodopa5.1 2. 1Aou should not take the antihistamine with our levodopa 24arodopa5.1 3. 1Aou should not take the multivitamin with our levodopa 24arodopa5.1 4. 10hese medications are sa!e to take with levodopa 24arodopa5.1 Corre!t Ans"er: % #ationa$e 1: Bitamin =: will decrease the e!!ects o! levodopa 24arodopa5& so the patient should not take a multivitamin while receiving levodopa 24arodopa5. Bitamin =: will decrease the e!!ects o! levodopa 24arodopa5& so the patient should not a take a multivitamin while receiving levodopa 24arodopa5. 0here isn"t an contraindication to the use o! aspirin and levodopa 24arodopa5. 0here isn"t an contraindication to the use o! an antihistamine and levodopa 24arodopa5. #ationa$e 2: Bitamin =: will decrease the e!!ects o! levodopa 24arodopa5& so the patient should not take a multivitamin while receiving levodopa 24arodopa5. Bitamin =: will decrease the e!!ects o! levodopa 24arodopa5& so the patient should not a take a multivitamin while receiving levodopa 24arodopa5. 0here isn"t an contraindication to the use o! aspirin and levodopa 24arodopa5. 0here isn"t an contraindication to the use o! an antihistamine and levodopa 24arodopa5. #ationa$e 3: Bitamin =: will decrease the e!!ects o! levodopa 24arodopa5& so the patient should not take a multivitamin while receiving levodopa 24arodopa5. Bitamin =: will decrease the e!!ects o! levodopa 24arodopa5& so the patient should not a take a multivitamin while receiving levodopa 24arodopa5. 0here isn"t an contraindication to the use o! aspirin and levodopa 24arodopa5. 0here isn"t an contraindication to the use o! an antihistamine and levodopa 24arodopa5. #ationa$e 4: Bitamin =: will decrease the e!!ects o! levodopa 24arodopa5& so the patient should not take a multivitamin while receiving levodopa 24arodopa5. Bitamin =: will decrease the e!!ects o! levodopa 24arodopa5& so the patient should not a take a multivitamin while receiving levodopa 24arodopa5. 0here isn"t an contraindication to the use o! aspirin and levodopa 24arodopa5. 0here isn"t an contraindication to the use o! an antihistamine and levodopa 24arodopa5. %$o&a$ #ationa$e: Co'niti(e )e(e$: Anal zing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: .mplementation )earnin' ,ut!ome: +,/' Question / Type: MCSA
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

0he elderl patient receives levodopa 24arodopa5. 0he nurse is primaril concerned about which problem with this patient? 1. # pertension 2. 3iarrhea 3. Muscle twitching 4. 3ark urine Corre!t Ans"er: % #ationa$e 1: Muscle twitching ma indicate to8icit . Constipation& not diarrhea& is a side e!!ect o! levodopa 24arodopa5. 3ark urine is a normal !inding associated with this medication. # potension& not h pertension is possible with levodopa 24arodopa5. #ationa$e 2: Muscle twitching ma indicate to8icit . Constipation& not diarrhea& is a side e!!ect o! levodopa 24arodopa5. 3ark urine is a normal !inding associated with this medication. # potension& not h pertension is possible with levodopa 24arodopa5. #ationa$e 3: Muscle twitching ma indicate to8icit . Constipation& not diarrhea& is a side e!!ect o! levodopa 24arodopa5. 3ark urine is a normal !inding associated with this medication. # potension& not h pertension is possible with levodopa 24arodopa5. #ationa$e 4: Muscle twitching ma indicate to8icit . Constipation& not diarrhea& is a side e!!ect o! levodopa 24arodopa5. 3ark urine is a normal !inding associated with this medication. # potension& not h pertension is possible with levodopa 24arodopa5. %$o&a$ #ationa$e: Co'niti(e )e(e$: Anal zing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: $lanning )earnin' ,ut!ome: +,/' Question 0 Type: MCSA 0he patient receives levodopa and carbidopa 2Sinemet5. What will the best teaching b the nurse include as relates to this medication? 1. Avoid drinking ca!!einated beverages. 2. 0ake the medication with meals.
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

3. 0ake the medication on an empt stomach. 4. 0ake the medication with a protein !ood. Corre!t Ans"er: % #ationa$e 1: 4evodopa and carbidopa 2Sinemet5 should be taken on an empt stomach !or better absorption. 4evodopa and carbidopa 2Sinemet5 should not be taken with meals; this will decrease absorption. 4evodopa and carbidopa 2Sinemet5 should not be taken with a protein !ood; this will decrease absorption. 0here isn"t an signi!icant relationship between ca!!eine and 4evodopa and carbidopa 2Sinemet5. #ationa$e 2: 4evodopa and carbidopa 2Sinemet5 should be taken on an empt stomach !or better absorption. 4evodopa and carbidopa 2Sinemet5 should not be taken with meals; this will decrease absorption. 4evodopa and carbidopa 2Sinemet5 should not be taken with a protein !ood; this will decrease absorption. 0here isn"t an signi!icant relationship between ca!!eine and 4evodopa and carbidopa 2Sinemet5. #ationa$e 3: 4evodopa and carbidopa 2Sinemet5 should be taken on an empt stomach !or better absorption. 4evodopa and carbidopa 2Sinemet5 should not be taken with meals; this will decrease absorption. 4evodopa and carbidopa 2Sinemet5 should not be taken with a protein !ood; this will decrease absorption. 0here isn"t an signi!icant relationship between ca!!eine and 4evodopa and carbidopa 2Sinemet5. #ationa$e 4: 4evodopa and carbidopa 2Sinemet5 should be taken on an empt stomach !or better absorption. 4evodopa and carbidopa 2Sinemet5 should not be taken with meals; this will decrease absorption. 4evodopa and carbidopa 2Sinemet5 should not be taken with a protein !ood; this will decrease absorption. 0here isn"t an signi!icant relationship between ca!!eine and 4evodopa and carbidopa 2Sinemet5. %$o&a$ #ationa$e: Co'niti(e )e(e$: Anal zing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: .mplementation )earnin' ,ut!ome: +,/@ Question 10 Type: MCSA 0he patient has been diagnosed with Alzheimer"s disease. What is the best medication education the nurse gives to the patient"s husband? 1. 10he medication ma help her s mptoms !or a little while.1 2. 10he medication has serious side e!!ects i! used !or a long time.1 3. 1#er s mptoms will improve as long as she takes the medication.1 4. 1#er s mptoms should begin improving in a !ew da s.1
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

Corre!t Ans"er: #ationa$e 1: Medications will onl slow the progression o! the disease. .mprovement with medication usuall onl lasts a matter o! months. .t takes a minimum o! - to ( weeks to begin to see improvement. 0he medications do not have serious side e!!ects and are usuall not used over a long period o! time. #ationa$e 2: Medications will onl slow the progression o! the disease. .mprovement with medication usuall onl lasts a matter o! months. .t takes a minimum o! - to ( weeks to begin to see improvement. 0he medications do not have serious side e!!ects and are usuall not used over a long period o! time. #ationa$e 3: Medications will onl slow the progression o! the disease. .mprovement with medication usuall onl lasts a matter o! months. .t takes a minimum o! - to ( weeks to begin to see improvement. 0he medications do not have serious side e!!ects and are usuall not used over a long period o! time. #ationa$e 4: Medications will onl slow the progression o! the disease. .mprovement with medication usuall onl lasts a matter o! months. .t takes a minimum o! - to ( weeks to begin to see improvement. 0he medications do not have serious side e!!ects and are usuall not used over a long period o! time. %$o&a$ #ationa$e: Co'niti(e )e(e$: Anal zing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: .mplementation )earnin' ,ut!ome: +,/: Question 11 Type: MCSA 0he nurse is teaching a class !or caregivers o! patients with Alzheimer"s disease. 0he nurse determines that learning has occurred when the caregivers make which statement? 1. C0here aren"t an drugs that are e!!ective in treating this disease.1 2. 10here are e!!ective drugs& but the cannot be used over a long period.1 3. 10here are drugs that will help decrease s mptoms !or a little while.1 4. 10here are drugs that can control s mptoms !or man Corre!t Ans"er: % #ationa$e 1: Current medications will onl decrease s mptoms !or a little while. 0here are drugs that will decrease s mptoms !or a short period o! time. 3rugs will not control s mptoms !or man ears. 0he drugs !or treatment o! Alzheimer"s disease are no more dangerous than other drugs used !or a long period o! time. ears.1

Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

#ationa$e 2: Current medications will onl decrease s mptoms !or a little while. 0here are drugs that will decrease s mptoms !or a short period o! time. 3rugs will not control s mptoms !or man ears. 0he drugs !or treatment o! Alzheimer"s disease are no more dangerous than other drugs used !or a long period o! time. #ationa$e 3: Current medications will onl decrease s mptoms !or a little while. 0here are drugs that will decrease s mptoms !or a short period o! time. 3rugs will not control s mptoms !or man ears. 0he drugs !or treatment o! Alzheimer"s disease are no more dangerous than other drugs used !or a long period o! time. #ationa$e 4: Current medications will onl decrease s mptoms !or a little while. 0here are drugs that will decrease s mptoms !or a short period o! time. 3rugs will not control s mptoms !or man ears. 0he drugs !or treatment o! Alzheimer"s disease are no more dangerous than other drugs used !or a long period o! time. %$o&a$ #ationa$e: Co'niti(e )e(e$: Anal zing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: *valuation )earnin' ,ut!ome: +,/> Question 12 Type: MCSA 0he patient has $arkinson"s disease& and develops depression. What is the best education the nurse can give the patient"s !amil ? 1. 1An time someone has a brain disease& depression will result.1 2. 13epression is ver eas to treat with medications we have available.1 3. 10his is a common problem with $arkinson"s disease.1 4. 10his is a result o! the medications taken !or control o! s mptoms.1 Corre!t Ans"er: % #ationa$e 1: 3epression is common with an chronic& debilitating disease. 0he medications are not the cause o! the depression. $atients with a neurological illness do not alwa s develop depression. 3epression is treatable with medications& but this does not help the !amil to understand what is happening with the patient. #ationa$e 2: 3epression is common with an chronic& debilitating disease. 0he medications are not the cause o! the depression. $atients with a neurological illness do not alwa s develop depression. 3epression is treatable with medications& but this does not help the !amil to understand what is happening with the patient. #ationa$e 3: 3epression is common with an chronic& debilitating disease. 0he medications are not the cause o! the depression. $atients with a neurological illness do not alwa s develop depression. 3epression is treatable with medications& but this does not help the !amil to understand what is happening with the patient.
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

#ationa$e 4: 3epression is common with an chronic& debilitating disease. 0he medications are not the cause o! the depression. $atients with a neurological illness do not alwa s develop depression. 3epression is treatable with medications& but this does not help the !amil to understand what is happening with the patient. %$o&a$ #ationa$e: Co'niti(e )e(e$: Anal zing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: .mplementation )earnin' ,ut!ome: +,/( Question 13 Type: MCSA 0he patient receives trihe8 phenid l 2Artane5 !or $arkinson"s disease. Which assessment data will the nurse report to the ph sician? 1. 3r mouth 2. Anore8ia 3. # pertension 4. Drinar retention Corre!t Ans"er: ( #ationa$e 1: Drinar retention is a serious side e!!ect that must be reported to the ph sician. 3r mouth is a common side e!!ect o! trihe8 phenid l 2Artane5 that does not need reporting. # pertension is not a side e!!ect o! trihe8 phenid l 2Artane5. Anore8ia is not a side e!!ect o! trihe8 phenid l 2Artane5. #ationa$e 2: Drinar retention is a serious side e!!ect that must be reported to the ph sician. 3r mouth is a common side e!!ect o! trihe8 phenid l 2Artane5 that does not need reporting. # pertension is not a side e!!ect o! trihe8 phenid l 2Artane5. Anore8ia is not a side e!!ect o! trihe8 phenid l 2Artane5. #ationa$e 3: Drinar retention is a serious side e!!ect that must be reported to the ph sician. 3r mouth is a common side e!!ect o! trihe8 phenid l 2Artane5 that does not need reporting. # pertension is not a side e!!ect o! trihe8 phenid l 2Artane5. Anore8ia is not a side e!!ect o! trihe8 phenid l 2Artane5. #ationa$e 4: Drinar retention is a serious side e!!ect that must be reported to the ph sician. 3r mouth is a common side e!!ect o! trihe8 phenid l 2Artane5 that does not need reporting. # pertension is not a side e!!ect o! trihe8 phenid l 2Artane5. Anore8ia is not a side e!!ect o! trihe8 phenid l 2Artane5. %$o&a$ #ationa$e: Co'niti(e )e(e$: Anal zing
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: Assessment )earnin' ,ut!ome: +,/' Question 14 Type: MCSA 0he patient receives tacrine 2Cogne85 as treatment !or Alzheimer"s disease. Which laborator test2s5 will the nurse primaril assess? 1. Serum am lase levels 2. Complete blood count 3. Eenal !unction tests 4. 4iver !unction tests Corre!t Ans"er: ( #ationa$e 1: 0acrine 2Cogne85 is hepatoto8ic and reFuires monitoring o! liver !unction tests 24<0s5 in an patient who is receiving this drug. 0acrine 2Cogne85 does not a!!ect renal !unction; so monitoring o! renal !unction tests is not reFuired. 0acrine 2Cogne85 does not a!!ect pancreatic !unction; so monitoring o! serum am lase levels is not reFuired. 0acrine 2Cogne85 does not a!!ect blood counts; so monitoring o! complete blood counts 2C=C5 is not reFuired. #ationa$e 2: 0acrine 2Cogne85 is hepatoto8ic and reFuires monitoring o! liver !unction tests 24<0s5 in an patient who is receiving this drug. 0acrine 2Cogne85 does not a!!ect renal !unction; so monitoring o! renal !unction tests is not reFuired. 0acrine 2Cogne85 does not a!!ect pancreatic !unction; so monitoring o! serum am lase levels is not reFuired. 0acrine 2Cogne85 does not a!!ect blood counts; so monitoring o! complete blood counts 2C=C5 is not reFuired. #ationa$e 3: 0acrine 2Cogne85 is hepatoto8ic and reFuires monitoring o! liver !unction tests 24<0s5 in an patient who is receiving this drug. 0acrine 2Cogne85 does not a!!ect renal !unction; so monitoring o! renal !unction tests is not reFuired. 0acrine 2Cogne85 does not a!!ect pancreatic !unction; so monitoring o! serum am lase levels is not reFuired. 0acrine 2Cogne85 does not a!!ect blood counts; so monitoring o! complete blood counts 2C=C5 is not reFuired. #ationa$e 4: 0acrine 2Cogne85 is hepatoto8ic and reFuires monitoring o! liver !unction tests 24<0s5 in an patient who is receiving this drug. 0acrine 2Cogne85 does not a!!ect renal !unction; so monitoring o! renal !unction tests is not reFuired. 0acrine 2Cogne85 does not a!!ect pancreatic !unction; so monitoring o! serum am lase levels is not reFuired. 0acrine 2Cogne85 does not a!!ect blood counts; so monitoring o! complete blood counts 2C=C5 is not reFuired. %$o&a$ #ationa$e: Co'niti(e )e(e$: Anal zing
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: Assessment )earnin' ,ut!ome: +,/@ Question 1 Type: MCSA Which o! the !ollowing degenerative diseases o! the central nervous s stem is the most common? 1. Am otrophic lateral sclerosis 2. $arkinsonGs 3. Multiple sclerosis 4. #untingtonGs chorea Corre!t Ans"er: + #ationa$e 1: $arkinsonGs and AlzheimerGs diseases are the most common degenerative diseases o! the central nervous s stem. #ationa$e 2: $arkinsonGs and AlzheimerGs diseases are the most common degenerative diseases o! the central nervous s stem. #ationa$e 3: $arkinsonGs and AlzheimerGs diseases are the most common degenerative diseases o! the central nervous s stem. #ationa$e 4: $arkinsonGs and AlzheimerGs diseases are the most common degenerative diseases o! the central nervous s stem. %$o&a$ #ationa$e: Co'niti(e )e(e$: Eemembering C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: Assessment )earnin' ,ut!ome: +,/Question 1Type: MCSA Muscle sti!!ness& pill/rolling activit & and brad kinesia are s mptoms most likel associated with which disorder? 1. $arkinsonGs disease
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

2. Multiple sclerosis 3. AlzheimerGs disease 4. Am otrophic lateral sclerosis Corre!t Ans"er: #ationa$e 1: $arkinsonGs disease has several s mptoms& including muscle sti!!ness& pill/rolling activit & and brad kinesia. #ationa$e 2: $arkinsonGs disease has several s mptoms& including muscle sti!!ness& pill/rolling activit & and brad kinesia. #ationa$e 3: $arkinsonGs disease has several s mptoms& including muscle sti!!ness& pill/rolling activit & and brad kinesia. #ationa$e 4: $arkinsonGs disease has several s mptoms& including muscle sti!!ness& pill/rolling activit & and brad kinesia. %$o&a$ #ationa$e: Co'niti(e )e(e$: Eemembering C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: Assessment )earnin' ,ut!ome: +,/+ Question 1. Type: MCSA $harmacotherap !or $arkinsonGs disease is intended to 1. increase the amount o! dopamine and reduce the amount o! acet lcholine. 2. increase the amount o! dopamine and acet lcholine. 3. reduce the amount o! dopamine and increase the amount o! acet lcholine. 4. reduce the amount o! dopamine and acet lcholine. Corre!t Ans"er: #ationa$e 1: $arkinsonGs disease results in the death o! neurons that produce dopamine. 3ue to the imbalance& dopamine is provided 2levodopa5& and anticholinergics can be administered as well. #ationa$e 2: $arkinsonGs disease results in the death o! neurons that produce dopamine. 3ue to the imbalance& dopamine is provided 2levodopa5& and anticholinergics can be administered as well.
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

#ationa$e 3: $arkinsonGs disease results in the death o! neurons that produce dopamine. 3ue to the imbalance& dopamine is provided 2levodopa5& and anticholinergics can be administered as well. #ationa$e 4: $arkinsonGs disease results in the death o! neurons that produce dopamine. 3ue to the imbalance& dopamine is provided 2levodopa5& and anticholinergics can be administered as well. %$o&a$ #ationa$e: Co'niti(e )e(e$: Dnderstanding C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: $lanning )earnin' ,ut!ome: +,/% Question 1/ Type: MCSA <rom a pharmacolog standpoint& which o! the !ollowing best e8plains wh levodopa is superior to dopamine? 1. .t crosses the bloodHbrain barrier. 2. .t has !ewer adverse e!!ects. 3. .t has less risk !or addiction. 4. .t can be administered orall . Corre!t Ans"er: #ationa$e 1: 4evodopa can cross the bloodHbrain barrier& where dopamine cannot. 4evodopa administration leads directl to dopamine s nthesis. #ationa$e 2: 4evodopa can cross the bloodHbrain barrier& where dopamine cannot. 4evodopa administration leads directl to dopamine s nthesis. #ationa$e 3: 4evodopa can cross the bloodHbrain barrier& where dopamine cannot. 4evodopa administration leads directl to dopamine s nthesis. #ationa$e 4: 4evodopa can cross the bloodHbrain barrier& where dopamine cannot. 4evodopa administration leads directl to dopamine s nthesis. %$o&a$ #ationa$e: Co'niti(e )e(e$: Eemembering C$ient *eed: $s chosocial .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: $lanning
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

)earnin' ,ut!ome: +,/@ Question 10 Type: MCSA Which o! the !ollowing best e8plains wh structural changes occur within the brains o! people with AlzheimerGs disease? 1. .ncreased acet lcholine levels 2. .ncreases in blood pressure and cholesterol levels 3. Chronic in!lammation and o8idate cellular damage 4. Cerebral bleeding and associated h po8ia Corre!t Ans"er: % #ationa$e 1: AlzheimerGs disease is characterized b am loid plaFues and neuro!ibrillar tangles that most likel occur !rom chronic in!lammation or o8idative cellular damage. #ationa$e 2: AlzheimerGs disease is characterized b am loid plaFues and neuro!ibrillar tangles that most likel occur !rom chronic in!lammation or o8idative cellular damage. #ationa$e 3: AlzheimerGs disease is characterized b am loid plaFues and neuro!ibrillar tangles that most likel occur !rom chronic in!lammation or o8idative cellular damage. #ationa$e 4: AlzheimerGs disease is characterized b am loid plaFues and neuro!ibrillar tangles that most likel occur !rom chronic in!lammation or o8idative cellular damage. %$o&a$ #ationa$e: Co'niti(e )e(e$: Eemembering C$ient *eed: $s chosocial .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: Assessment )earnin' ,ut!ome: +,/' Question 20 Type: MCSA Which o! the !ollowing would most likel be an initial treatment !or a patient with AlzheimerGs disease? 1. 4evodopa 24arodopa5 2. #aloperidol 2#aldol5
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

3. =enztropine mes late 2Cogentin5 4. 3onepezil h drochloride 2Aricept5 Corre!t Ans"er: ( #ationa$e 1: 3onepezil h drochloride 2Aricept5 is an acet lcholinesterase inhibitor& and the most !reFuentl used drug !or AlzheimerGs disease. 4evodopa 24arodopa5 and benztropine mes late 2Cogentin5 are used !or $arkinsonGs disease. #aloperidol 2#aldol5 can be used in some cases o! AlzheimerGs disease& but due to its adverse e!!ects is not !reFuentl used. #ationa$e 2: 3onepezil h drochloride 2Aricept5 is an acet lcholinesterase inhibitor& and the most !reFuentl used drug !or AlzheimerGs disease. 4evodopa 24arodopa5 and benztropine mes late 2Cogentin5 are used !or $arkinsonGs disease. #aloperidol 2#aldol5 can be used in some cases o! AlzheimerGs disease& but due to its adverse e!!ects is not !reFuentl used. #ationa$e 3: 3onepezil h drochloride 2Aricept5 is an acet lcholinesterase inhibitor& and the most !reFuentl used drug !or AlzheimerGs disease. 4evodopa 24arodopa5 and benztropine mes late 2Cogentin5 are used !or $arkinsonGs disease. #aloperidol 2#aldol5 can be used in some cases o! AlzheimerGs disease& but due to its adverse e!!ects is not !reFuentl used. #ationa$e 4: 3onepezil h drochloride 2Aricept5 is an acet lcholinesterase inhibitor& and the most !reFuentl used drug !or AlzheimerGs disease. 4evodopa 24arodopa5 and benztropine mes late 2Cogentin5 are used !or $arkinsonGs disease. #aloperidol 2#aldol5 can be used in some cases o! AlzheimerGs disease& but due to its adverse e!!ects is not !reFuentl used. %$o&a$ #ationa$e: Co'niti(e )e(e$: Eemembering C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: $lanning )earnin' ,ut!ome: +,/: Question 21 Type: MCSA Which statement is the most accurate regarding acet lcholinesterase inhibitors when used !or Alzheimer"s disease? 1. 0he reverse the structural damage within the brain. 2. 0he increase s nthesis o! acet lcholine. 3. 0he increase enz matic breakdown& leading to increased neuronal production. 4. 0he intensi! the e!!ect o! acet lcholine at the receptor.
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

Corre!t Ans"er: ( #ationa$e 1: Acet lcholinesterase inhibitors intensi! the e!!ect o! acet lcholine at the receptor. 0he do not increase acet lcholine s nthesis or enz matic breakdown. Currentl no drugs can reverse the structural damages associated with AlzheimerGs disease. #ationa$e 2: Acet lcholinesterase inhibitors intensi! the e!!ect o! acet lcholine at the receptor. 0he do not increase acet lcholine s nthesis or enz matic breakdown. Currentl no drugs can reverse the structural damages associated with AlzheimerGs disease. #ationa$e 3: Acet lcholinesterase inhibitors intensi! the e!!ect o! acet lcholine at the receptor. 0he do not increase acet lcholine s nthesis or enz matic breakdown. Currentl no drugs can reverse the structural damages associated with AlzheimerGs disease. #ationa$e 4: Acet lcholinesterase inhibitors intensi! the e!!ect o! acet lcholine at the receptor. 0he do not increase acet lcholine s nthesis or enz matic breakdown. Currentl no drugs can reverse the structural damages associated with AlzheimerGs disease. %$o&a$ #ationa$e: Co'niti(e )e(e$: Eemembering C$ient *eed: $h siological .ntegrit C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: Assessment )earnin' ,ut!ome: +,/> Question 22 Type: MCMA What will the nurse include when teaching a caregivers" support group about Alzheimer"s disease? Note: Credit will be given only if all correct choices and no incorrect choices are selected. Standard Text: Select all that appl . 1. 7lutamergic inhibitors are the most common class o! drugs !or treating Alzheimer"s disease. 2. 3epression and aggressive behavior are common with the disease. 3. Memor di!!iculties are an earl s mptom o! the disease. 4. Chronic in!lammation o! the brain can be a cause o! the disease. . $harmacologic therapies are given to help improve memor in Alzheimer"s disease. Corre!t Ans"er: +&%&(&' #ationa$e 1: 7lutamergic inhibitors are not the most common class o! drugs !or treating Alzheimer"s disease.
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

#ationa$e 2: 3epression and aggressive behavior are common s mptoms o! the disease. #ationa$e 3: Memor di!!iculties are an earl s mptom o! Alzheimer"s disease. #ationa$e 4: .t is suspected that chronic in!lammation and e8cess !ree radicals can cause neuron damage and contribute to the disease. #ationa$e : 0he acet lcholinesterase inhibitors are the most widel used class o! drugs !or treating the disease. 0hese drugs work b increasing the availabilit o! acet lcholine. Acet lcholine is involved in cognition& memor & and learning. %$o&a$ #ationa$e: Co'niti(e )e(e$: Appl ing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: Eeduction o! Eisk $otential *ursin'/+nte'rated Con!epts: Nursing $rocess: $lanning )earnin' ,ut!ome: +,/' Question 23 Type: MCMA A patient is diagnosed with multiple sclerosis. What s mptoms will the nurse most likel assess in this patient? Note: Credit will be given only if all correct choices and no incorrect choices are selected. Standard Text: Select all that appl . 1. Muscle weakness 2. 3i!!icult maintaining balance 3. Atroph o! the hands and legs 4. Slow shu!!ling gait . $rogressive chorea Corre!t Ans"er: -&+ #ationa$e 1: Muscle weakness is a mani!estation o! multiple sclerosis. #ationa$e 2: 3i!!icult maintaining balance is a mani!estation o! multiple sclerosis. #ationa$e 3: Atroph o! the hands and legs is not a mani!estation o! multiple sclerosis. #ationa$e 4: A slow shu!!ling gait is not a mani!estation o! multiple sclerosis.
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

#ationa$e : $rogressive chorea is not a mani!estation o! multiple sclerosis. %$o&a$ #ationa$e: Co'niti(e )e(e$: Anal zing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: Eeduction o! Eisk $otential *ursin'/+nte'rated Con!epts: Nursing $rocess: Assessment )earnin' ,ut!ome: +,/Question 24 Type: MCMA 0he nurse observes a patient with $arkinson"s disease having di!!icult controlling hand movements. What did the nurse observe in this patient? Note: Credit will be given only if all correct choices and no incorrect choices are selected. Standard Text: Select all that appl . 1. $ill rolling 2. 0remor 3. Stooped posture 4. 4ack o! arm swing . 3i!!icult bending the arms Corre!t Ans"er: -&+ #ationa$e 1: $ill rolling is a common behavior in progressive $arkinson"s disease in which the patient rubs the thumb and !ore!inger together in a circular motion resembling the motion o! rolling a tablet between two !ingers. #ationa$e 2: 0he hands develop a pals /like continuous motion or shaking when at rest. #ationa$e 3: A stooped posture would not in!luence the patient"s abilit to control hand movements. #ationa$e 4: A lack o! arm swing does not in!luence the patient"s abilit to control hand movements. #ationa$e : 3i!!icult bending the arms does not in!luence the patient"s abilit to control hand movements. %$o&a$ #ationa$e: Co'niti(e )e(e$: Anal zing C$ient *eed: #ealth $romotion and Maintenance
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

C$ient *eed Su&: *ursin'/+nte'rated Con!epts: Nursing $rocess: Assessment )earnin' ,ut!ome: +,/% Question 2 Type: MCMA A patient with $arkinson"s disease is e8periencing an increase in brad kinesia. What will the patient demonstrate with this mani!estation? Note: Credit will be given only if all correct choices and no incorrect choices are selected. Standard Text: Select all that appl . 1. Slow speech 2. 3i!!icult chewing 3. Shu!!ling the !eet when walking 4. Stooped posture . 4ack o! !acial e8pression Corre!t Ans"er: -&+&% #ationa$e 1: Slow speech is a mani!estation o! brad kinesia. #ationa$e 2: 3i!!icult chewing is a mani!estation o! brad kinesia. #ationa$e 3: Shu!!ling the !eet when walking is a mani!estation o! brad kinesia. #ationa$e 4: Stooped posture is not a mani!estation o! brad kinesia. #ationa$e : 4ack o! !acial e8pression is not a mani!estation o! brad kinesia. %$o&a$ #ationa$e: Co'niti(e )e(e$: Anal zing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: $h siological Adaptation *ursin'/+nte'rated Con!epts: Nursing $rocess: Assessment )earnin' ,ut!ome: +,/% Question 2Type: S*I
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

0he nurse is e8plaining to a patient with $arkinson"s disease the steps in which the neurotransmitter dopamine !unctions to impact motor movement. .n which order will the nurse e8plain these steps? Standard Text: Click and drag the options below to move them up or down. Corre!t Ans"er: %$o&a$ #ationa$e: Co'niti(e )e(e$: Appl ing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: Eeduction o! Eisk $otential *ursin'/+nte'rated Con!epts: Nursing $rocess: .mplementation )earnin' ,ut!ome: +,/( Question 2. Type: MCMA 0he nurse& providing medications to a patient with multiple sclerosis& realizes that the goals o! medication therap !or this patient include Note: Credit will be given only if all correct choices and no incorrect choices are selected. Standard Text: Select all that appl . 1. modi! ing the progression o! the disease. 2. treating acute e8acerbations. 3. managing s mptoms. 4. curing the disease. . rem elinating nerve !ibers. Corre!t Ans"er: -&+&% #ationa$e 1: 0his is a goal o! pharmacologic therap !or multiple sclerosis. #ationa$e 2: 0his is a goal o! pharmacologic therap !or multiple sclerosis. #ationa$e 3: 0his is a goal o! pharmacologic therap !or multiple sclerosis. #ationa$e 4: 0his is not a goal o! pharmacologic therap !or multiple sclerosis. #ationa$e : 0his is not a goal o! pharmacologic therap !or multiple sclerosis. %$o&a$ #ationa$e:
Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.

Co'niti(e )e(e$: Anal zing C$ient *eed: $h siological .ntegrit C$ient *eed Su&: $harmacological and $arenteral 0herapies *ursin'/+nte'rated Con!epts: Nursing $rocess: $lanning )earnin' ,ut!ome: +,/9

Adams, Pharmacology for Nurse: A Pathophysiologic Approach, ()* Cop right +,-( b $earson *ducation& .nc.